XM does not provide services to residents of the United States of America.

Indian shares see worst week since mid-March as volatility, foreign selling weighs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares see worst week since mid-March as volatility, foreign selling weighs</title></head><body>

Updates with closing levels at 3:30 p.m. IST

By Bharath Rajeswaran and Hritam Mukherjee

BENGALURU, May 10 (Reuters) -Indian shares ended higher on Friday, but logged their worst week in eight as concerns over the outcome of ongoing national elections and selling by foreign investors weighed on sentiment.

The blue-chip NSE Nifty 50 .NSEI was up 0.44% at 22,055.20 points, while the S&P BSE Sensex .BSESN advanced 0.36% to 72,664.47, at close.

The benchmarks, however, logged their worst week since mid-March, dropping about 1.8% each and snapping two straight weeks of gains. Thevolatility index .NIFVIX gained 386 percentage points duringthe week to touch 18.47, a19-month high.

A lower voter turnout so far in India's general election has raised questions whetherPrime Minister Narendra Modi's Bharatiya Janata Party (BJP) and its allies can achieve the landslide victory predicted by opinion polls just a month ago. Counting of votes is scheduled for June 4.


Meanwhile, intense foreign selling - with investors offloading Indian shares worth $1.2 billion so far in May and paving course for the highest Foreign Portfolio Investment (FPI) sale since January - also pressured sentiment.

"Considering the higher risk-to-return ratio in India, expensive valuations and no indication of rate cuts happening immediately in the U.S., foreign investors have taken some money off the table," said Anita Gandhi, founder and head of institution at Arihant Capital Markets.

The recent strong performance of Chinese indices is also a trigger, prompting a shift of foreign inflows from the Indian to the Chinese market, said Santosh Pandey, president and head of Nuvama Professional Clients Group.


On Friday, nine of the 13 major sectors logged gains.

Drugmaker Cipla CIPL.NS fell 1.42% after it missed fourth-quarter revenue estimates. However, pharma stocks .NIPHARM ended 0.94% higher, cushioned by a 3.16%jump in Abbott India ABOT.NS after its quarterlyresults.

Energy stocks .NIFTYENR ended 1.64% higher, led by a 4.48% post-results rise in Bharat Petroleum Corp BPCL.NS as its margins outshone peers.

BPCL was also the top gainer on the Nifty 50 index, on the day.


MSCI EM index outperforms India's Nifty 50 in 2024 https://reut.rs/3UsoXW8

FPI selling in Indian shares intensifies in May https://reut.rs/3wqnLKZ

Weekly performance of India's key sectoral indexes https://reut.rs/3UzwN0e

Weekly performance of India's Nifty 50 stocks https://reut.rs/4busr13


Reporting by Hritam Mukherjee and Bharath Rajeswaran in Bengaluru; Editing by Savio D'Souza and Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.